Canadian Stocks Beat the S&P 500 Nearly 2-to-1 Last Year: Should You "Buy Canadian"?

Canadian equities materially outperformed U.S. stocks last year (S&P/TSX +28.3% vs S&P 500 +16.4%), driven by a heavier weight in banks and natural-resource names, a lower sector concentration in tech, and supportive domestic fiscal plans that boosted defense and resource companies (Bombardier doubled in a few months in 2025; Cameco +50%). The TSX trades at a cheaper average P/E (~20) versus the S&P 500 (~29.5), and the iShares MSCI Canada ETF (EWC) returned 36% in 2025, with a five-year annualized return of 14.12% and a 0.50% expense ratio — the piece recommends EWC as a diversified, cost-efficient way to access 84 Canadian stocks. Key macro drivers cited include lower Canadian rates (~2.3%) relative to U.S. policy rates and reduced U.S. tech froth, supporting a continued case for Canadian exposure.

Analysis

Market structure: The rotation out of U.S. mega-cap tech into Canada benefits Canadian banks, commodity producers and defense/aerospace names (e.g., BBD.B.TO, CCJ) because TSX sector weights are resource- and financial-heavy and TSX P/E (≈20) trades well below S&P 500 (≈29.5). That P/E gap plus fiscal/infrastructure stimulus in Canada implies continued relative flows into EWC-like vehicles; expect commodity-linked cash flows to support equities while tech multiples decompress near-term.

Risk assessment: Tail risks include a sudden Fed pivot (rate cuts >50bps through H2 2026) re-igniting U.S. tech multiple expansion, a sharp CAD appreciation >5% that compresses USD-denominated miner margins, or stalled Canadian stimulus/permit delays that derail resource projects. Near-term (days–weeks) momentum matters; medium-term (3–12 months) depends on policy execution and commodity supply shocks; long-term (>12 months) hinges on structural capex and global commodity cycles.

Trade implications: Implement diversified Canadian exposure (broad ETF + selective resource/defense picks) while hedging US-tech sensitivity. Use relative-value pair trades (long CCJ/BBD.B.TO or EWC vs short QQQ or NVDA exposure) and option spreads to cap premium. Key triggers: Fed decision Apr 29, Canadian budget/infrastructure releases, quarterly earnings — act within 2–8 weeks around these dates.

Contrarian angles: Consensus underestimates concentration risk — TSX gains are commodity-driven and narrower than headline returns imply; EWC up 36% already suggests mean-reversion risk if commodity prices retreat. Historical parallels (TSX beats in resource cycles 2016–2017) show reversals when global growth or risk appetite normalizes; watch TSX breadth, CAD/USD ±5%, and TSX P/E moving toward 24 as early sell signals.

Key Decisions for Investors

• Establish a 2–3% portfolio long in iShares MSCI Canada ETF (EWC) scaled over 2–4 weeks; target holding 6–12 months, trim into strength at +20% or if TSX P/E >24, stop-loss at -8% to limit downside on mean reversion.
• Allocate 1–2% to long Cameco (CCJ) for uranium exposure tied to Canadian nuclear plans; hold 12–24 months, add on pullbacks of >10%, take profits at +40% or cut at -15% if quarterly guidance weakens.
• Initiate a pair trade: long 1% Bombardier BBD.B.TO (or equivalent Canadian aerospace) vs short 1% NVDA or 0.8% QQQ to express resource/defense vs US-AI tech rotation; horizon 3–6 months, unwind if NASDAQ outperforms TSX by >10% in 30 days.
• Purchase a small, defined-risk options position: 0.5% notional 3-month call spread on EWC (ATM to ATM+10%) to lever upside ahead of Apr–May policy/catalyst window; max loss = premium, target 2–4x return if TSX momentum continues.
• Reduce U.S. large-cap tech exposure by 5–10% (reallocate proceeds to above Canada/resource names) before Apr 29 Fed decision to de-risk policy-sensitive multiple contraction; restore allocation only if NASDAQ 30-day returns exceed TSX by >8%.